You are here

opioid crisis

Opioid supply crunch for U.S. coronavirus patients prompts appeal to relax limits

Opioid supply crunch for U.S. coronavirus patients prompts appeal to relax limits

Reuters

Flag link:

N.Y. postpones opioid bellwether trial as novel coronavirus concerns spread

N.Y. postpones opioid bellwether trial as novel coronavirus concerns spread

Fierce Pharma

Flag link:

Florida law limiting first opioid prescription linked to drop in use

Florida law limiting first opioid prescription linked to drop in use

Reuters

Flag link:

Endo touts financial 'flexibility' as massive opioid settlements mount industrywide

Endo touts financial 'flexibility' as massive opioid settlements mount industrywide

Fierce Pharma

Flag link:

U.S. states reject $18 billion proposal to settle opioid lawsuits, discussions ongoing: sources

U.S. states reject $18 billion proposal to settle opioid lawsuits, discussions ongoing: sources

Reuters

Flag link:

Insys founder John Kapoor sentenced to 5 1/2 years for orchestrating opioid scheme

Insys founder John Kapoor sentenced to 5 1/2 years for orchestrating opioid scheme

Marketwatch

INSYS Therapeutics

Flag link:

Purdue, maker of OxyContin, quietly splits ways with PhRMA as it pulls back from lobbying

Purdue, maker of OxyContin, quietly splits ways with PhRMA as it pulls back from lobbying

Stat

Flag link:

Audit: Sackler family took $10B from Purdue Pharma amid opioid suits

Audit: Sackler family took $10B from Purdue Pharma amid opioid suits

UPI

Flag link:

The history of OxyContin, told through unsealed Purdue documents

The history of OxyContin, told through unsealed Purdue documents

Stat

Flag link:

Six Drug Companies Subpoenaed In Federal Opioid Investigation

Six Drug Companies Subpoenaed In Federal Opioid Investigation

Forbes

Teva Pharmaceutical

AmerisourceBergen

Flag link:

Purdue to Pay States’ Legal Fees to Expedite Release of Emergency Funds

Purdue to Pay States’ Legal Fees to Expedite Release of Emergency Funds

Fierce Pharma

Flag link:

OxyContin maker thrives in China with abandoned U.S. tactics

OxyContin maker thrives in China with abandoned U.S. tactics

Stat

Flag link:

How Purdue planted its ‘anti-story’ and delayed the reckoning for its role in the opioid epidemic

How Purdue planted its ‘anti-story’ and delayed the reckoning for its role in the opioid epidemic

Stat

Flag link:

J&J kicks back at Oklahoma politicians' move to squeeze out more opioid payments: report

J&J kicks back at Oklahoma politicians' move to squeeze out more opioid payments: report

Fierce Pharma

Flag link:

Daiichi Sankyo pulls out of U.S. pain market amid oncology pivot, opioid scrutiny

Daiichi Sankyo pulls out of U.S. pain market amid oncology pivot, opioid scrutiny

Fierce Pharma

Flag link:

Justice Department issues grand jury subpoenas in J&J opioid probe: filing

Justice Department issues grand jury subpoenas in J&J opioid probe: filing

Yahoo/Reuters

Flag link:

J&J slashes third-quarter profit by $3 bln over proposed opioid deal

J&J slashes third-quarter profit by $3 bln over proposed opioid deal

Yahoo/Reuters

Flag link:

Several states wary of $48 billion opioid settlement proposal

Several states wary of $48 billion opioid settlement proposal

Yahoo/Reuters

Amerisource Bergen

Cardinal Health

Teva Pharmaceutical

Flag link:

Teva offers colossal $23.3B opioid 'framework' deal to escape thousands of lawsuits

Teva offers colossal $23.3B opioid 'framework' deal to escape thousands of lawsuits

Fierce Pharma

Teva Pharmaceutical

Flag link:

Drug distributors and Teva reach tentative settlement of opioids lawsuit

Drug distributors and Teva reach tentative settlement of opioids lawsuit

Stat

Teva Pharmaceutical

AmerisourceBergen

Cardinal Health

Flag link:

Pages